lemme glp 1 dupe Inc., co-founded by Kourtney Kardashian, was accused in a new proposed class action for advertising its GLP1 supplement as working like FDA approved medications like semaglutide and tirzepatide. #ozempic #kardashians #wegovy # Lemme Faces New Class-Action Lawsuit

doi:10.1177/2042018821997320 33

When combining insights from Morningstar Sustainalytics ESG Risk Ratings and Morningstar Equity Research (depicted in Exhibit 1), we find that Pfizer PFE and Roche RHHBY stand out as potential top choices among potential future market entrants, whereas Novo Nordisk NVO appears undervalued among current players

Still, peptide therapy is not something to approach casually

Additionally, further investigations are underway to explore potential additional uses of tirzepatide in the clinical management of other cardiometabolic conditions associated with obesity, including heart failure and non-alcoholic (or metabolic-dysfunction associated) steatohepatitis (NASH/MASH)